Transcription of the prorenin gene in normal and diseased breast

• Published in: European journal of cancer (1990) 1998-10, Vol.34 (11), p.1777-1782
• Main Authors: Tahmasebi, M, Puddefoot, J.R, Inwang, E.R, Goode, A.W, Carpenter, R, Vinson, G.P
• Format: Article
• Language: English
• Subjects: Ang II AT1 receptor; Biological and medical sciences; breast cancer; Breast Diseases - genetics; Enzyme Precursors - genetics; Female; Gynecology. Andrology. Obstetrics; Humans; immunocytochemistry; Immunohistochemistry - methods; in situ hybridisation; In Situ Hybridization; Mammary gland diseases; Medical sciences; prorenin mRNA; Receptors, Angiotensin - metabolism; Renin - genetics; RNA, Messenger - metabolism; Transcription, Genetic; Tumors
• ISSN: 0959-8049; 1879-0852
• DOI: 10.1016/S0959-8049(98)00173-7

The angiotensin II type 1 (AT1) receptor is present in a wide variety of human and animal tissues, and is particularly abundant in epithelial cells. Because of this, and because it is known that tissue renin angiotensin systems (RASs) exist that have specific local functions, we investigated the expression and localisation of components of the RAS in normal and diseased breast tissue. Using a monoclonal antibody to the AT1 receptor, immunocytochemistry confirmed that the AT1 receptor was characteristically distributed in ductal epithelial cells in both normal and malignant tissue, and in most, although not all, cells in invasive tumours. Transcription of prorenin mRNA was studied by in situ hybridisation, using a DIG-ddUTP tail-labelled probe specific for the human prorenin gene. In normal tissue, and in cases of ductal carcinoma in situ, prorenin mRNA was distributed in myoepithelial cells and in a band of connective tissue cells completely surrounding the AT1-containing ductal epithelial cells. This prorenin transcribing tissue was disrupted and attenuated in invasive tumours, and in some of these, prorenin mRNA transcription could not be detected at all. Functions ascribed to the tissue RASs include regulation of mitosis and tissue modelling, as well as fluid and electrolyte transport. The results presented here strongly suggest the possibility that a tissue RAS may also be present in the breast, closely coupled to the provision of angiotensin II to the AT1 receptors in ductal epithelial cells. This mechanism is disrupted in cancer.